http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-9306844-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2b9dc89cc4ba060cc73bbf0c90bbb78
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
filingDate 1993-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_123b8ffcaf5460cda2002f105db51a95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_123e73e40f33cd0f4b9dbb3faea3fa9d
publicationDate 1995-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-9306844-A
titleOfInvention NOVELTY COMPOUNDS THAT HAVE PHARMACOLOGICAL ACTIVITY, PROCESS FOR SUPREPARATION AND PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM.
abstract The invention describes the compounds of formula (I) and the pharmaceutically acceptable salts thereof, and the use of the compounds of formula (I) or the pharmaceutically acceptable salts thereof: wherein X is a monocyclic or polycyclic aromatic group, Y is O or NH; Z is of the sub-formula: where - (CH2) n1 is attached to carbon; and n1 is 0, 1, 3 or 4, q is 0, 1, 2 or 3; Ra is a straight or branched chain alkylene whose length is 1-6 carbon atoms substituted in the terminal part by R7, where R7 is aryl, a 3-8 membered cycloalkyl, 3-8 membered heterocyclyl, a 5- or monocyclic heteroaryl 6-membered or 9- or 10-membered bicyclic heteroaryl attached through carbon, or R7 is a C2-7 alkoxycarbonyl or a substituted hydroxy or C1-6 alkyl secondary; and R6 is hydrogen or C1-6 alkyl; or a compound of formula (I) wherein the CO-Y bond is replaced by a bio-hetero-heterocyclic; and its use as a pharmaceutical product in the treatment of gastrointestinal disorders, cardiovascular disorders, and CNS disorders.
priorityDate 1992-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974

Total number of triples: 26.